Announced
Completed
Financials
Sources
Tags
Completed
Single Bidder
Private
Biotechnology
Spain
Acquisition
Friendly
Domestic
drugs developing
Majority
Synopsis
Esteve, a pharmaceutical company, completed the acquisition of Lliçà de Vall plant from Uquifa, a manufacturer of pharmaceutical products. Financial terms were not disclosed. "It is a strategic acquisition that will allow Esteve to increase its productive capacity by 20% and help Vivimed focus on the rest of the production centers," Pere Mañé, Esteve Director of Operations.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.